Rainer Lichtenberger, Ph.D. MBA
More than 30 years management in life science Industry, EVP Merckle/ratiopharm group for BD; Since 16 years CEO/COO experience in several SME, raised € 80 Mn venture funds.Read more
Christian Wallasch, Ph.D.
Seasoned executive management member (COO, CEO) in biopharmaceuticals SME, as Axxima and U3, as well as public companies like Intercell/Valneva. Expert in kinase inhibitors, vaccines development, project management and execution.Read more
20 years of Biotech industry, active as entrepreneur, manager, deal maker, Co-founder, CEO and CFO of CellMed AG, MD of AEterna Zentaris, 10 years Private Equity & M&A-AdvisoryRead more
Stephan Stenglein, M.D.
Physician trained in Clinical and Molecular Virology with 20 years of accomplishments in pharma, medical device and vaccine development. Previous global management positions with Novartis and AstraZeneca.Read more
Prof. Oliver Planz, Ph.D.
Universität D-Tübingen,Co-inventor of the technology, expert in antiviral research und translational preclinical R&D up to clinical studies. Advises the WHO on antiviral strategies against influenza.Read more
Björn Cochlovius, Ph.D., Assoc. Prof.
VP Business Development
20 years leadership positions in SMEs (Head R&D Affitech, CEO OnTarget) and big pharma (Roche, Otsuka, Abbvie). Working experiences in Europe and Asia. Background in R&D, Business Development, M&A, FinancingRead more